Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MBX
MBX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MBX News
MBX Biosciences CEO Increases Shareholding
4d ago
Fool
MBX Biosciences Reports Q4 2025 Financial Results
Mar 12 2026
seekingalpha
Mbx Biosciences Shares Hit Oversold Signal
Mar 09 2026
NASDAQ.COM
MBX Biosciences Completes EOP2 Meeting with FDA for Canvuparatide
Mar 09 2026
Newsfilter
MBX Biosciences Completes FDA Meeting, Advances New Drug Trial
Mar 09 2026
Newsfilter
Overview of 13D Filings
Feb 21 2026
Yahoo Finance
Analyst Target Prices Indicate Potential for Pharmaceuticals ETF
Jan 29 2026
NASDAQ.COM
MBX Biosciences Advances Obesity Drug Development with Strong Cash Position
Jan 11 2026
Globenewswire
MBX Biosciences Updates on 2026 Clinical Progress and Strong Cash Position
Jan 11 2026
Newsfilter
Monte Rosa Therapeutics Shares Surge 45.2% After Phase 1 Data Release
Jan 07 2026
Benzinga
Microbix Launches First Recombinant Antigen Product for COVID-19 Testing
Jan 07 2026
Yahoo Finance
MBX Biosciences to Present Novel Therapies at 44th J.P. Morgan Healthcare Conference
Dec 15 2025
Newsfilter
Microbix Biosystems to Release Q4 2025 Financial Results on December 18, 2025
Dec 11 2025
Globenewswire
Microbix Biosystems to Release Q4 2025 Financial Results on December 18, 2025
Dec 11 2025
Newsfilter
Microbix Launches QAPs for H3N2 Flu Testing
Dec 10 2025
Globenewswire
Microbix Launches QAPs for H3N2 Flu Testing
Dec 10 2025
Newsfilter
Show More News
